How Much Would It Take To Earn $100 A Month From Pfizer Stock?

Pfizer PFE discovers, develops, manufactures, markets, distributes and sells biopharmaceutical products in the United States, Europe and internationally.

It will report its Q4 2024 earnings on Jan. 28, 2025. Wall Street analysts expect the company to post an EPS of $0.68, up from $0.10 in the year-ago period. According to data from Benzinga Pro, quarterly revenue is expected to be $18.09 billion, up from $14.25 billion a year ago.

Don't Miss:

• This Jeff Bezos-backed startup will allow you to become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.
• Commercial real estate has historically outperformed the stock market, and this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!

The 52-week range of Pfizer’s stock price was $24.48 to $31.54.

Pfizer’s dividend yield is 6.52%. During the last 12 months, it paid $1.68 per share in dividends.

The Latest On Pfizer

On Oct. 29, the company announced its Q3 2024 earnings, posting adjusted EPS of $1.06, a turnaround from a loss of 17 cents a year ago. This beat the consensus of $0.62, as reported by Benzinga.

The U.S. drugmaker reported sales of $17.70 billion, up 31% year-over-year (up 32% operationally), beating the consensus of $14.95 billion. The increase was primarily led by growth contributions from Paxlovid, several acquired products, key in-line products and recent commercial launches.

Pfizer updated its 2024 revenue forecast to $61-$64 billion compared to prior guidance of $59.5-$62.5 billion and a consensus of $61.16 billion.

Check out this article by Benzinga, which analyzes Pfizer’s recent short interest.

See Also: Over the last five years, the price of gold has increased by approximately 83% — Investors like Bill O’Reilly and Rudy Giuliani are using this platform to create customized gold IRAs to help shield their savings from inflation and economic turbulence. 

How Can You Earn $100 Per Month As A Pfizer Investor?

If you want to make $100 per month –$1,200 annually – from Pfizer dividends, your investment value needs to be approximately $18,405, which equals 711 shares at $25.88 each. 

Understanding dividend yield calculations: When making an estimate, you need two key variables – the desired annual income ($1,200) and the dividend yield (6.52%). So, $1,200 / 0.0652 = $18,405 to generate an income of $100 per month.

You can calculate the dividend yield by dividing the annual dividend payments by the stock’s current price.

The dividend yield can change over time due to fluctuating stock prices and dividend payments on a rolling basis.

Trending: If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it?

For instance, assume a stock that pays $2 as an annual dividend is priced at $50. Its dividend yield would be $2/$50 = 4%. If the stock price rises to $60, the dividend yield drops to 3.33% ($2/$60). A drop in stock price to $40 will have an inverse effect and increase the dividend yield to 5% ($2/$40).

In summary, income-focused investors may find Pfizer stock an attractive option for making a steady income of $100 per month by owning 711 shares of stock. There may be more upside as investors benefit from the company's consistent dividend hikes. Pfizer has raised its dividend consecutively for the last 14 years. 

Wondering if your investments can get you to a $5,000,000 nest egg? Speak to a financial advisor today. SmartAsset’s free tool matches you up with up to three vetted financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.

Arrived Achieved A Total Return of 34.7% On Their Biggest Sale Yet — Diversify Your Monthly Income Stream With Fractional Real Estate

Arrived allows individuals to invest in shares of rental properties for as little as $100, providing the potential for monthly rental income and long-term appreciation without the hassles of being a landlord. With over $1 million in dividends paid out last quarter and a growing selection of properties across various markets, Arrived offers an attractive alternative for investors seeking to build a diversified real estate portfolio. 

In October 2024, Arrived sold The Centennial, achieving a total return of 34.7% (11.2% average annual returns) for investors. Arrived aims to continue delivering similar value across our portfolio through careful market selection, attentive property management, and thoughtful timing in sales.

Looking for fractional real estate investment opportunities? The Benzinga Real Estate Screener features the latest offerings.